The Cigna Group

The Cigna Group

CINYSE / NASDAQHealthcareLarge cap

$270.90-$2.14 (-0.8%)

Last close · Data as of Nov 20, 2026

Market cap
$74.2B
P/E
12.5x
EV / EBITDA
10.2x
Revenue
$274.9B
Net margin
2.2%
ROCE
12.6%

+0.5% over the last year

The Cigna Group price, 1Y

Daily closes.

Go deeper

Technical chart: candles, 28 indicators including moving averages, RSI and MACD, drawing tools and five colour themes

Open technical chart
Open technical chartCandles, 28 indicators, drawing tools

Performance

Price return, before dividends, to the 20 Nov 2026 close.

1M
-11.6%
3M
-1.3%
6M
-4.3%
1Y
+0.5%
5Y
+28.7%

52-week range

Day change -$2.14 (-0.8%) from $273 to $271 · Last close Nov 20, 2026

Best weekday to invest, historically

The same weekly amount in CI, bought on each weekday since 2021.

News & filings

What The Cigna Group filed, who traded, and what's next

How to read this

"News & filings" lists what the company itself has put on record with regulators, who inside it traded, the news that names it, and the next date we know of. Filings and releases are first-hand; news is third-party and may be thin for smaller companies. A day of insider filings is one row. Nothing here is a recommendation.

AI Summary

US Stock

ConcernOther income of 216.7 billion US dollars was 79% of revenue in fiscal 2025.

Strengths (1)

  • Operating profit was 6.5 times interest costs.

Prices to the 20 Nov 2026 close · Financial year: fiscal 2025

Rule-based from financial data. Not advice.

About the company

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It operates through two segments: Evernorth Health Services and Cigna Healthcare.

Read moreShow less

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It operates through two segments: Evernorth Health Services and Cigna Healthcare. The Evernorth Health Services segment includes Pharmacy Benefit Services and Specialty and Care Services, offering pharmacy benefit management, drug claim adjudication, retail pharmacy network administration, benefit design consultation, drug utilization review, drug formulary management, pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty pharmaceutical distribution, and clinical programs for whole-person health outcomes. The Cigna Healthcare segment comprises U.S. Healthcare and International Health, delivering comprehensive medical and coordinated solutions such as employer medical plans, individual and family plans, behavioral health, consumer health engagement, dental, pharmacy management, stop-loss insurance, global health care, and local health care solutions, as well as health care benefits for mobile individuals and employees of multinational organizations. The company offers other operations, including corporate-owned life insurance, reinsurance, and certain run-off and non-strategic businesses. The company distributes its products and services through brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.

Sector
Healthcare
Shares outstanding
268.6M

Valuation, profitability, growth and solvency at the latest close; hover a label for its meaning.

Valuation

Market cap
$74.2B
P/E
12.5x
P/B
1.8x
EV / EBITDA
10.2x
EV / Sales
0.4x
P/S
0.3x
52-week high
$315.88
52-week low
$258.08

Profitability

Operating margin
3.1%
Net margin
2.2%
EBITDA margin
3.4%
ROE
14.3%
ROCE
12.6%
ROA
3.8%
Asset turnover
1.74

Growth

Revenue
$274.9B
Revenue growth, 1Y
11.7%
Revenue CAGR, 3Y
15.3%
Net profit growth, 1Y
73.5%
Free cash flow
$8.4B

Solvency

Current ratio
0.85
Debt / Equity
0.75
Debt / Assets
0.20
CFO / Net profit
1.61
Cash / Market cap
10.3%

Where the revenue went

Some FY2025 lines are not reported, so the ones that are appear as a table.

LineFY2025
Revenue$274.9B
Gross profit$274.9B
Operating expenses—
Selling, general and administrative$14.6B
Pretax income$7.8B
Tax and other$1.8B
Net income$6.0B

Revenue and net profit

Revenue grew 11.7% in FY2025; net profit is the dashed line.

The Cigna Group revenue and net profit by fiscal year
The Cigna Group revenue and net profit by fiscal year
DateRevenueNet profit
FY2022$179.4B$6.7B
FY2023$4.85T$25.8B
FY2024$246.1B$3.4B
FY2025$274.9B$6.0B

Cash flows

FY2025: $9.6B from operations, $8.4B free after investment (dashed).

The Cigna Group operating and free cash flow by fiscal year
The Cigna Group operating and free cash flow by fiscal year
DateOperating cash flowFree cash flow
FY2022$8.7B$7.4B
FY2023$11.8B$10.2B
FY2024$10.4B$9.0B
FY2025$9.6B$8.4B

Growth

Latest fiscal year 2025: each figure with its change over the year before.

Revenue
$274.9B+11.7%1Y
Net profit
$6.0B+73.5%1Y
Cash from operations
$9.6B-7.4%1Y
Free cash flow
$8.4B-6.3%1Y
Revenue CAGR, 3Y
15.3%
Net profit CAGR, 3Y
-3.9%
YearRevenueEBITDANet profitFCFROERevenue growth 1YNet profit growth 1Y
FY2025$274.9B—$6.0B$8.4B14.3%+11.7%+73.5%

Monthly returns

Month-by-month returns of CI across the years, with the seasonal pattern.

Balance sheet

What the company owns and owes at the end of FY2025.

LineFY2025
Assets$157.9B
Liabilities$116.0B
Equity$41.9B
Paid-in capital$31.8B
Retained earnings$47.9B
Treasury stock$35.1B
Minority interest$161.0M

Market cap against peers

8 peers: same sector, nearest by size.

Peers map

Healthcare companies placed by value, growth and quality; CI highlighted.

P/E against peers

CI trades at 12.5x earnings against a peer median of 22.1x (a 44% discount).

Peer comparison

Same-sector peers by market cap, with the median.

CompanyMarket capP/EP/BROEEV/EBITDA
The Cigna GroupCIthis companyP/E ↓ discount$74.2B12.5x1.8x14.3%10.2x
McKesson CorporationMCK$91.0B19.1x-41.9x-219.2%13.3x
Elevance Health, Inc.ELV$88.9B15.7x2.0x12.9%—
HCA Healthcare, Inc.HCA$80.3B11.8x-13.3x-112.6%8.2x
Boston Scientific CorporationBSX$72.6B25.1x3.0x12.0%16.1x
Regeneron Pharmaceuticals, Inc.REGN$65.9B14.6x2.1x14.4%11.3x
Cencora, Inc.COR$52.6B33.8x34.9x103.1%14.9x
Edwards Lifesciences CorporationEW$50.4B46.9x4.9x10.4%33.2x
Cardinal Health, Inc.CAH$47.2B30.3x-17.0x-56.1%16.7x
Peer median—22.1x2.1x11.2%14.9x

Year-to-date ROI

CI since 1 January, against earlier years.

Historical volatility

CI's day-to-day swings over 30, 60 and 180 days.

Financial statements

Income statement, balance sheet and cash flow as reported, grouped into plain-language lines.

Consolidated figures in USD, fiscal years, newest first.

Operating margin by fiscal year

The Cigna Group operating margin by fiscal year
The Cigna Group operating margin by fiscal year
DateOperating margin
FY20224.1%
FY2023-1.8%
FY20243.4%
FY2025—
LineFY2025
Cost of revenueCost Of Revenue—
Gross profitGross Profit—
Operating expensesOperating Expense—
Selling, general and administrativeSelling General And Administration$14.6B
Other operating expensesOther Operating Expenses$215.0B
Depreciation and amortisationDepreciation And Amortization In Income Statement$1.7B
Depreciation, amortisation and depletionDepreciation Amortization Depletion Income Statement—
Amortization$1.7B
Amortisation of intangiblesAmortization Of Intangibles Income Statement—
Total expensesTotal Expenses$267.1B
Pretax incomePretax Income$7.8B

Learn while you research

Academy chapters picked for The Cigna Group and the metrics on this page.

  1. 01 Stock Valuation BasicsHow to think about what a fair price for a stock looks like.7 min read
  2. 02 Sector Analysis MattersHealthcare valuation is driven by pipelines and regulation, not just numbers.6 min read
  3. 03 Essential Stock RatiosP/E, P/B, EV/EBITDA, what they mean and when to use each.7 min read
  4. 04 How to Read a Cash-Flow StatementProfit can be manipulated; cash flow rarely lies.7 min read
Browse the full Equiscale Academy →